Praxis Precision’s relutrigine reduces seizures in rare epileptic disorders in phase 2 clinical trials
Relutrigine resulted in a 46% reduction in seizures and seizure freedom in 30% of patients. Patients also experienced meaningful improvements ...
Relutrigine resulted in a 46% reduction in seizures and seizure freedom in 30% of patients. Patients also experienced meaningful improvements ...
1. In a systematic review and meta-analyses of dietary interventions for drug-resistant epilepsy in children, the ketogenic diet, modified Atkins diet, ...
1. Amongst a cohort of individuals with arterial hypertension, those who were taking angiotensin receptor blocker antihypertensives had the lowest ...
1. The risk of cancer was higher amongst children of mothers with epilepsy who were exposed to high-dose folic acid ...
1. In this retrospective cohort study, among 261 patients with status epilepticus, age, duration, and nonconvlusive status epilepticus in coma ...
1. Individuals treated with lamotrigine had significantly lower cardiovascular and all-cause mortality compared to those treated with carbamazepine, whereas patients ...
Evidence Rating Level: 2 (Good) 1. Transdermal cannabidiol gel was found to be a safe and effective treatment for children ...
Evidence Rating Level: 1 (Excellent) 1. There were no language ability differences among 2-year-old children of women taking epileptic medication ...
1. No significant difference in functional neurodevelopment was found at 24 months in infants who continued to take antiseizure medication ...
1. 12-month remission was superior with valproate than with levetiracetam. 2. Compared to levetiracetam, patients in the valproate group reported ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.